课题基金 / 基金详情

The Effect of Gender-Affirming Hormone Therapy on Cardiovascular Risk Factors and Outcomes in Transgender Women

The Effect of Gender-Affirming Hormone Therapy on Cardiovascular Risk Factors and Outcomes in Transgender Women
性别肯定激素治疗对跨性别女性心血管危险因素和结果的影响
批准号:
458517
负责人:
Rytz Chantal
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-11-01 至 2024-11-01

项目摘要

项目成果

Rytz Chantal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transgender women (assigned male at birth with woman gender identity) have poor heart health. Yet, they are an understudied population in healthcare and research. To gain feminizing features, transgender women may use gender-affirming estrogen therapy. Ho
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serum Estradiol Levels and Cardiovascular Risk Associated with Gender-Affirming Hormone use in Transgender Women: A Systematic Review and Meta-Analysis
  • 批准号:
    480726
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2023
  • 负责人:
    Rytz Chantal
  • 依托单位:
Establishing Validated Algorithms for Identifying Transgender Women and Men Using Routinely Collected Healthcare Administrative Data in Alberta, Canada
  • 批准号:
    495225
  • 项目类别:
  • 资助金额:
    $0.15万
  • 财政年份:
    2023
  • 负责人:
    Rytz Chantal
  • 依托单位:
Cardiovascular Health in Transgender Hormone-Therapy Research Priority Setting
  • 批准号:
    480849
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.09万
  • 财政年份:
    2023
  • 负责人:
    Rytz Chantal
  • 依托单位:
海外基金